153 related articles for article (PubMed ID: 25031569)
1. Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis.
Kumar S; Jena L; Galande S; Daf S; Mohod K; Varma AK
Genomics Inform; 2014 Jun; 12(2):64-70. PubMed ID: 25031569
[TBL] [Abstract][Full Text] [Related]
2. In Silico Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18.
Kumar S; Jena L; Sahoo M; Kakde M; Daf S; Varma AK
Genomics Inform; 2015 Jun; 13(2):60-7. PubMed ID: 26175664
[TBL] [Abstract][Full Text] [Related]
3. Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein.
Kumar S; Jena L; Mohod K; Daf S; Varma AK
Interdiscip Sci; 2015 Jun; 7(2):136-42. PubMed ID: 26199214
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein.
Kumar S; Jena L; Mohod K; Daf S; Varma AK
Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25663107
[TBL] [Abstract][Full Text] [Related]
5. In silico analyzing the molecular interactions of plant-derived inhibitors against E6AP, p53, and c-Myc binding sites of HPV type 16 E6 oncoprotein.
Nabati F; Moradi M; Mohabatkar H
Mol Biol Res Commun; 2020 Jun; 9(2):71-82. PubMed ID: 32802901
[TBL] [Abstract][Full Text] [Related]
6. Elucidating Molecular Interactions of Ten Natural Compounds Targeting E6 HPV High Risk Oncoproteins Using Microsecond Molecular Dynamics Simulations.
Meza-Menchaca T; Lizano-Soberón M; Trigos A; Zepeda RC; Medina ME; Galindo-Murillo R
Med Chem; 2021; 17(6):587-600. PubMed ID: 31995016
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery.
Kolluru S; Momoh R; Lin L; Mallareddy JR; Krstenansky JL
BMC Mol Cell Biol; 2019 Aug; 20(1):30. PubMed ID: 31387520
[TBL] [Abstract][Full Text] [Related]
8. In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein.
Soumia M; Hajji H; El Mzibri M; Younes FZ; Mohammed B; Mohamed B; Benaissa M
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146532
[TBL] [Abstract][Full Text] [Related]
9. Molecular Landscape and Computational Screening of the Natural inhibitors against HPV16 E6 Oncoprotein.
Juneja T; Pandya MD; Shah S
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2461-2469. PubMed ID: 34452559
[TBL] [Abstract][Full Text] [Related]
10. An in silico appraisal of azoic and disulphide derivatives for anticancer activity against HPV E6 oncoprotein to medicate cervical cancer.
Choudhury AD; Choudhury MD; Chetia P; Chowdhury A; Talukdar AD
Comb Chem High Throughput Screen; 2014 Jan; 17(1):38-46. PubMed ID: 24164050
[TBL] [Abstract][Full Text] [Related]
11. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
Celegato M; Messa L; Goracci L; Mercorelli B; Bertagnin C; Spyrakis F; Suarez I; Cousido-Siah A; Travé G; Banks L; Cruciani G; Palù G; Loregian A
Cancer Lett; 2020 Feb; 470():115-125. PubMed ID: 31693922
[TBL] [Abstract][Full Text] [Related]
12. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
13. Computer aided screening of natural compounds targeting the E6 protein of HPV using molecular docking.
Mamgain S; Sharma P; Pathak RK; Baunthiyal M
Bioinformation; 2015; 11(5):236-42. PubMed ID: 26124567
[TBL] [Abstract][Full Text] [Related]
14. Taxifolin and Lucidin as Potential E6 Protein Inhibitors: p53 Function Re-Establishment and Apoptosis Induction in Cervical Cancer Cells.
Gomes D; Yaduvanshi S; Silvestre S; Duarte AP; Santos AO; Soares CP; Kumar V; Passarinha L; Sousa Â
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740499
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.
Chen TH; Huang CC; Yeh KT; Chang SH; Chang SW; Sung WW; Cheng YW; Lee H
World J Gastroenterol; 2012 Aug; 18(30):4051-8. PubMed ID: 22912557
[TBL] [Abstract][Full Text] [Related]
16. Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors.
Rietz A; Petrov DP; Bartolowits M; DeSmet M; Davisson VJ; Androphy EJ
PLoS One; 2016; 11(2):e0149845. PubMed ID: 26915086
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
18. HPV infection and p53 inactivation in pterygium.
Tsai YY; Chang CC; Chiang CC; Yeh KT; Chen PL; Chang CH; Chou MC; Lee H; Cheng YW
Mol Vis; 2009 Jun; 15():1092-7. PubMed ID: 19503739
[TBL] [Abstract][Full Text] [Related]
19. Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.
Illiano E; Demurtas OC; Massa S; Di Bonito P; Consalvi V; Chiaraluce R; Zanotto C; De Giuli Morghen C; Radaelli A; Venuti A; Franconi R
J Transl Med; 2016 Jul; 14(1):224. PubMed ID: 27465494
[TBL] [Abstract][Full Text] [Related]
20. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
